the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Worldwide Wound Management, 2009: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

Published by MedMarket Diligence Contact us : +1-860-674-8796
Published 2009/09 Content info 266 pages, 59 Exhibits, 71 Company Profiles
Product code MED98660
Price From  US $ 3250 Order/Price list
US $ 3250 Hard Copy
US $ 3250 PDF by E-mail (Single User License)
US $ 3450 PDF by E-mail (Single User License) & Hard Copy
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

EXECUTIVE SUMMARY

  • Acute Wounds
  • Burns
  • Chronic Wounds
  • Products Used in Advanced Wound Management
    • Film Dressings
    • Hydrocolloid Dressings
    • Foam Dressings
    • Alginate Dressings
    • Hydrogels
    • Non-Adherent Dressings
    • Anti-Microbial Dressings
    • Wound Cleansers and Debriding Agents
    • Skin Replacements and Substitutes
    • Pharmacological Products
    • Physical Therapies
  • The Market
  • The Industry

SECTION 1: BACKGROUND

  • 1.1 Industry Structure
  • 1.2 A Complex Industry
  • 1.3 Major Wound Management Corporations
  • 1.4 Historical Perspective and Technology Breakthroughs
  • 1.5 Worldwide Regulatory and Reimbursement Environment
    • 1.5.1 Cost Effectiveness
    • 1.5.2 Clinical
    • 1.5.3 Regulatory
    • 1.5.4 Reimbursement
      • 1.5.4.1 U.S.A
      • 1.5.4.2 European Union
      • 1.5.4.3 France
      • 1.5.4.4 Germany
      • 1.5.4.5 United Kingdom .
      • 1.5.4.6 Italy
      • 1.5.4.7 Belgium
      • 1.5.4.8 Spain
      • 1.5.4.9 Scandinavia.
  • 1.6 Geographical Differences in Treatments of Wounds
  • 1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
  • 1.8 Wound Management Trends
    • 1.8.1 Surgical Wounds
    • 1.8.2 Traumatic Wounds
    • 1.8.3 Burns
    • 1.8.4 Chronic Wounds
  • 1.9 Market Dynamics

SECTION 2: CLINICAL BACKGROUND AND CASELOAD

  • 2.1 Background
    • 2.1.1 A Few Figures
    • 2.1.2 Overview of Functions
    • 2.1.3 Skin Anatomy: A Summary
  • 2.2 Types of Wounds
    • 2.2.1 Classification By Severity
    • 2.2.2 Classification By Morphology
    • 2.2.3 Classification By Etiology
    • 2.2.4 Color Classification
  • 2.3 Surgical Wounds
  • 2.4 Traumatic Wounds
  • 2.5 Burns
    • 2.5.1 Debridement
    • 2.5.2 Grafting
  • 2.6 Pressure Ulcers
    • 2.6.1 Ulcer Classification
    • 2.6.2 Hospital-Acquired Ulcers
    • 2.6.3 Management of Pressure Ulcers
  • 2.7 Venous Ulcers
  • 2.8 Arterial Ulcers
  • 2.9 Diabetic Ulcers
    • 2.9.1 Prevalence
    • 2.9.2 Stages of Diabetic Ulcer
    • 2.9.3 Treatment
      • 2.9.3.1 Amputations
      • 2.9.3.2 Abnormal Scarring
    • 2.9.4 Acquired Immunodeficiency Syndrome
  • 2.10 Wound Healing Physiology
    • 2.10.1 Inflammatory Phase
    • 2.10.2 Proliferative Phase
      • 2.10.2.1 Angiogenesis
    • 2.10.3 Maturation Phase
  • 2.11 Factors Affecting Wound Healing
    • 2.11.1 Extrinsic Factors
    • 2.11.2 Mechanical Stress
    • 2.11.3 Debris
    • 2.11.4 Temperature
    • 2.11.5 Desiccation and Maceration
    • 2.11.6 Infection
    • 2.11.7 Chemical Stress
    • 2.11.8 Medication
    • 2.11.9 Other Extrinsic Factors
    • 2.11.10 Intrinsic Factors
    • 2.11.11 Health Status
    • 2.11.12 Age Factors
    • 2.11.13 Body Build
    • 2.11.14 Nutritional Status
  • 2.12 Major Treatment Categories and Regimes
  • 2.13 Incidence of Treatments, Growth Rates and Trends

SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS

  • 3.1 Background
  • 3.2 Film Dressings
    • 3.2.1 Overview
    • 3.2.2 Product Examples
    • 3.2.3 Market and Competitive Activity
  • 3.3 Hydrocolloids
    • 3.3.1 Overview
    • 3.3.2 Product Examples
    • 3.3.3 Market and Competitive Activity
  • 3.4 Foam Dressings
    • 3.4.1 Overview
    • 3.4.2 Product Examples
    • 3.4.3 Market and Competitive Activity
  • 3.5 Alginate Dressings
    • 3.5.1 Overview
    • 3.5.2 Product Examples
    • 3.5.3 Market and Competitive Activity
  • 3.6 Hydrogels
    • 3.6.1 Overview
    • 3.6.2 Product Examples
    • 3.6.3 Market and Competitive Activity
  • 3.7 Non-Adherent Dressings
    • 3.7.1 Overview
    • 3.7.2 Product Examples
    • 3.7.3 Market and Competitive Activity
  • 3.8 Antimicrobial Dressings
    • 3.8.1 Overview
    • 3.8.2 Product Examples
    • 3.8.3 Market and Competitive Activity
  • 3.9 Tissue-Engineered Products
    • 3.9.1 Overview
    • 3.9.2 Traditional Skin Grafts
    • 3.9.3 Skin Replacements
    • 3.9.4 Product Examples
    • 3.9.5 Market and Competitive Analysis
  • 3.10 Pharmacological Products
    • 3.10.1 Overview
    • 3.10.2 Product Examples
      • 3.10.2.1 Growth Factors
      • 3.10.2.2 Growth Factors: Background.
      • 3.10.2.3 Classification
      • 3.10.2.4 Other Growth Factors
      • 3.10.2.5 Non-Growth Factor Modulators
    • 3.10.3 Market and Competitive Analysis
      • 3.10.3.1 Growth Factors
      • 3.10.3.2 Non-Growth Factor Stimulants
      • 3.10.3.3 Gene Therapy
  • 3.11 Physical Treatments
    • 3.11.1 Negative Pressure Devices
    • 3.11.2 Positive Pressure Devices
    • 3.11.3 Mechanically Assisted Wound Closure
    • 3.11.4 Other Physical Wound Therapies
      • 3.11.4.1 Hydrotherapy
      • 3.11.4.2 Electrical Stimulation
      • 3.11.4.3 Electromagnetic Stimulation Devices
      • 3.11.4.4 Ultraviolet Therapy
      • 3.11.4.5 Hyperbaric Oxygen Therapy
      • 3.11.4.6 Ultrasound Devices
      • 3.11.4.7 Laser Devices
      • 3.11.4.8 Wound Imaging/Documentation
    • 3.11.5 Market and Competitive Analysis..
      • 3.11.5.1 Pressure Relief Devices.
      • 3.11.5.2 Hydrotherapy
      • 3.11.5.3 Electrical Stimulation
      • 3.11.5.4 Hyperbaric Oxygen Therapy .

SECTION 4: COUNTRY MARKET ANALYSIS

  • 4.1 Global Overview
  • 4.2 Market Estimates
    • 4.2.1 Market Potential
    • 4.2.2 Leading Wound Care Companies
    • 4.2.3 Leading National Markets .
  • 4.3 United States ...
    • 4.3.1 Market Opportunity.
    • 4.3.2 Market for Advanced Wound Management Products.
  • 4.4 Japan .
    • 4.4.1 Wound Care Market
    • 4.4.2 Market Opportunity.
    • 4.4.3 Leading Companies.
  • 4.5 Germany
    • 4.5.1 Wound Care Market
    • 4.5.2 Leading Companies.
  • 4.6 France .
    • 4.6.1 Wound Care Market
    • 4.6.2 Leading Companies.
  • 4.7 Italy.
    • 4.7.1 Wound Care Market
    • 4.7.2 Leading Companies.
  • 4.8 United Kingdom
    • 4.8.1 Wound Care Market
    • 4.8.2 Leading Companies

SECTION 5: COMPANY PROFILES

  • 5.1 Major Companies
    • 5.1.1 3M Health Care.
    • 5.1.2 Coloplast Group
      • 5.1.2.1 Financials
    • 5.1.3 ConvaTec Inc.
    • 5.1.4 Covidien
      • 5.1.4.1 Kendall
    • 5.1.5 Derma Sciences, Inc.
    • 5.1.6 DeRoyal Industries Inc.
    • 5.1.7 Ethicon (Johnson & Johnson)
    • 5.1.8 Gentell Inc.
    • 5.1.9 Geritrex Corp
    • 5.1.10 Hartmann Group
    • 5.1.11 Hollister Incorporated
    • 5.1.12 Lohmann & Rauscher International GmbH and Co. KG
    • 5.1.13 Medline Industries
    • 5.1.14 Molnlycke Health Care AB
    • 5.1.15 Smith & Nephew plc
    • 5.1.16 Systagenix Wound Management (US), Inc.
    • 5.1.17 UDL Laboratories
  • 5.2 Specialist Companies
    • 5.2.1 Antimicrobial Dressings
      • 5.2.1.1 AcryMed Inc.
      • 5.2.1.2 Argentum Products LLC
      • 5.2.1.3 Microban International Ltd
    • 5.2.2 Oxygen Therapy
      • 5.2.2.1 Perry Baromedical
    • 5.2.3 Tissue Regeneration
      • 5.2.3.1 Perry Baromedical
      • 5.2.3.2 Celltran Limited
      • 5.2.3.3 Euroderm AG
      • 5.2.3.4 Fidia Advanced Biopolymers
      • 5.2.3.5 Forticell Bioscience, Inc.
      • 5.2.3.6 Genzyme Biosurgery
      • 5.2.3.7 Integra LifeSciences Inc.
      • 5.2.3.8 Organogenesis Inc.
      • 5.2.3.9 Kinetic Concepts Inc.
        • 5.2.3.9.1 LifeCell Corporation
    • 5.2.4 Growth Factors
      • 5.2.4.1 ES Cell International
    • 5.2.5 Electrical Therapies
      • 5.2.5.1 BioMedical Life Systems, Inc.
      • 5.2.5.2 Diapulse Corporation of America
      • 5.2.5.3 Electromedical Products International Inc.
      • 5.2.5.4 Koldcare
      • 5.2.5.5 Microvas Technologies
    • 5.2.6 Odor Control
      • 5.2.6.1 CliniMed
    • 5.2.7 Other Therapeutic Modalities
      • 5.2.7.1 AGT Sciences Ltd
      • 5.2.7.2 Agennix
      • 5.2.7.3 Advanced Medical Solutions Group plc
      • 5.2.7.4 Anodyne Therapy LLC
      • 5.2.7.5 Applied Tissue Technologies
      • 5.2.7.6 Regenesis Biomedical Inc.
      • 5.2.7.7 Roho Inc.
      • 5.2.7.8 Uluru, Inc.
      • 5.2.7.9 Oculus Innovative Sciences, Inc.
    • 5.2.8 Summary Profiles
      • 5.2.8.1 AciesHealth
      • 5.2.8.2 Bard Medical Division
      • 5.2.8.3 Brennen Medical Inc.
      • 5.2.8.4 BSN medical Ltd
      • 5.2.8.5 DermaRite Industries LLC
      • 5.2.8.6 Ferris Manufacturing Corp.
      • 5.2.8.7 Fibrogen
      • 5.2.8.8 Geistlich Pharma.
      • 5.2.8.9 Healthpoint
      • 5.2.8.10 HemCon Medical Technologies
      • 5.2.8.11 Human BioSciences, Inc.
      • 5.2.8.12 Hymed Group Corporation
      • 5.2.8.13 Innocol, Inc.
      • 5.2.8.14 Laboratoires Urgo
      • 5.2.8.15 LifeWave Ltd
      • 5.2.8.16 Longport Inc.
      • 5.2.8.17 Nagor Ltd
      • 5.2.8.18 Oculus Innovative Sciences, Inc.
      • 5.2.8.19 Pioneer Surgical Technology, Inc.
      • 5.2.8.20 Unomedical
      • 5.2.8.21 Swiss American Products, Inc.
        • 5.2.8.21.1 Wound Care Products
      • 5.2.8.22 Wound Care Innovations, LLC

APPENDIX: LIST OF COMPANIES

List of Exhibits

  • Exhibit ES-1: Advanced Wound Care Market, by Segment, 2008 & 2017
  • Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2008
  • Exhibit 1-1: Worldwide Wound Prevalence by Etiology, 2008
  • Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2008 - 2017
  • Exhibit 2-1: Classification of Wounds by Etiology
  • Exhibit 2-2: Old and New Classification Systems for Burnss
  • Exhibit 3-1: Companies and Products in the Film Dressings Category
  • Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category
  • Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-7: Leading Companies and Products in the Foam Dressings Category
  • Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-10: Companies and Products in the Alginate Dressings Category
  • Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-13: Amorphous Hydrogels - Companies and Products
  • Exhibit 3-14: Impregnated Hydrogels - Companies and Products
  • Exhibit 3-15: Sheet Hydrogels, Companies and Products
  • Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category
  • Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-21: Companies and Products in the Antimicrobial Dressings Category
  • Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-24: Companies and Products in the Tissue Engineering Category
  • Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007, 2008
  • Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category
  • Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2008 - 2017
  • Exhibit 4-2: Leading Global Wound Care Companies by Market Share
  • Exhibit 4-3: Leading Global Wound Care Companies, Market Share, 2008
  • Exhibit 4-4: National Shares of the Global Advanced Wound Management Market, 2008
  • Exhibit 4-5: Forecast U.S. Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-6: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-7: Japanese Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-8: Japanese Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-9: German Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-10: German Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-11: French Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-12: French Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-13: Italian Sales for Advanced Wound Management Products, 2008 - 2016
  • Exhibit 4-14: Italian Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-15: UK Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-16: UK Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 5-1: Coloplast Revenues by Business Area (DKK Millions)
  • Exhibit 5-2: Selected Johnson & Johnson Medical Devices and Diagnostics Companies
  • Exhibit 5-3: Leading Advanced Wound Management Products and Suppliers
  • Exhibit 5-4: Integra LifeSciences Financial Data, 2007, 2008 ($ Millions), Year Ending Dec. 31
  • Exhibit 5-5: Financial Data for Uluru, Fiscal Year 2007 and 2008
  • Exhibit 5-6: Oculus Innovative Sciences, FY Fourth Quarter 2008 vs. 2009 Data (Year-End March 31)
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.